An enhanced monofocal IOL provided useful near and intermediate vision and “excellent” distance vision, according to a study ...
SOL-X long-term extension trial in wet AMD enrolled the first subject in April 2026 who had successfully completed the two-year SOL-1 trial ...
Guidance for 2026 assumes approximately $600 million in contract manufacturing revenue, with 2/3 occurring in the first half ...
To reliably complete various manual tasks, robots should be able to handle a variety of objects, ranging from items found in ...
Learn the key differences between polarized and non-polarized sunglasses, including glare reduction, eye protection, and ...
Ashvattha Therapeutics ("Ashvattha"), a clinical-stage company developing a nanomedicine therapeutic that traverses the blood-retinal barrier in areas of inflammation selectively targeting activated ...
Stealth BioTherapeutics (the "Company" or "Stealth"), a commercial-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving ...
The Department for Transport is currently holding a consultation on introducing mandatory eyesight checks for drivers over 70 ...
The health system's use of telemedicine has saved more than 3,000 hours of bedside nurse time, supported by more than 16,000 ...
Memory has limits but can be improved with focus, chunking, and spaced repetition. Testing recall and reducing distractions ...
Preoperative identification and eradication of Demodex can improve ocular-surface comfort and may mitigate cataract-surgery ...
Two major advances in cataract care were highlighted this week: Atia Vision’s shape-changing intraocular lens showed stable, high-quality vision over three years, and PRF Technologies gained FDA ...